title: The CroRS two-component regulatory system is required for intrinsic beta-lactam resistance in Enterococcus faecalis.
abstract: Enterococcus faecalis produces a specific penicillin-binding protein (PBP5) that mediates high-level resistance to the cephalosporin class of beta-lactam antibiotics. Deletion of a locus encoding a previously uncharacterized two-component regulatory system of E. faecalis (croRS) led to a 4,000-fold reduction in the MIC of the expanded-spectrum cephalosporin ceftriaxone. The cytoplasmic domain of the sensor kinase (CroS) was purified and shown to catalyze ATP-dependent autophosphorylation followed by transfer of the phosphate to the mated response regulator (CroR). The croR and croS genes were cotranscribed from a promoter (croRp) located in the rrnC-croR intergenic region. A putative seryl-tRNA synthetase gene (serS) located immediately downstream from croS did not appear to be a target of CroRS regulation or to play a role in ceftriaxone resistance. A plasmid-borne croRp-lacZ fusion was trans-activated by the CroRS system in response to the presence of ceftriaxone in the culture medium. The fusion was also induced by representatives of other classes of beta-lactam antibiotics and by inhibitors of early and late steps of peptidoglycan synthesis. The croRS null mutant produced PBP5, and expression of an additional copy of pbp5 under the control of a heterologous promoter did not restore ceftriaxone resistance. Deletion of croRS was not associated with any defect in the synthesis of the nucleotide precursor UDP-MurNAc-pentapeptide or of the D-Ala(4)-->L-Ala-L-Ala-Lys(3) peptidoglycan cross-bridge. Thus, the croRS mutant was susceptible to ceftriaxone despite the production of PBP5 and the synthesis of wild-type peptidoglycan precursors. These observations constitute the first description of regulatory genes essential for PBP5-mediated beta-lactam resistance in enterococci.
authors.affiliation: INSERM E0004-LRMA, UFR Broussais-Hôtel Dieu, Université Paris VI, 75270 Paris, France.
authors.forename: Yannick
authors.initials: Y
authors.lastname: Comenge
authors.forename: Richard
authors.initials: R
authors.lastname: Quintiliani
authors.forename: Ling
authors.initials: L
authors.lastname: Li
authors.forename: Lionnel
authors.initials: L
authors.lastname: Dubost
authors.forename: Jean-Paul
authors.initials: JP
authors.lastname: Brouard
authors.forename: Jean-Emmanuel
authors.initials: JE
authors.lastname: Hugonnet
authors.forename: Michel
authors.initials: M
authors.lastname: Arthur
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001426:Bacterial Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D002240:Carbohydrate Sequence; D002443:Ceftriaxone / Q000494:pharmacology; D002874:Chromosome Mapping; D003593:Cytoplasm / Q000378:metabolism; D013293:Enterococcus faecalis / Q000187:drug effects* / Q000235:genetics* / Q000378:metabolism; D017353:Gene Deletion; D008969:Molecular Sequence Data; D010457:Peptidoglycan / Q000378:metabolism; D011401:Promoter Regions, Genetic; D012333:RNA, Messenger; D018440:beta-Lactam Resistance / Q000502:physiology*
chemical_list: D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D010457:Peptidoglycan; D012333:RNA, Messenger; D002443:Ceftriaxone